among women with DCIS and early stage invasive cancer whom undergo MRI warrants further investigation.
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| INTRODUCTION
The trend away from radical mastectomy to breast conserving surgery (BCS) for treatment of breast cancer in the 1990s 1 has recently been shown to be shifting back towards more extensive surgical treatment in the last decade including for ductal carcinoma in situ (DCIS) and early stage invasive breast cancer. 1 MRI may be employed in the preoperative setting due to its high sensitivity for detecting otherwise occult disease not identified by mammography. [2] [3] [4] Prior studies report that more extensive surgeries are performed after preoperative MRI, including an extensive meta-analysis of surgical outcomes by Houssami et al, 5 which focused on studies that integrated a control group. [5] [6] [7] Such reports raise concerns that women may be undergoing more aggressive surgery related to MRI examinations, the benefit of which is uncertain because evidence has indicated that mastectomy is not always the superior treatment strategy. 8 At the same time, some reports suggest with the greater sensitivity and negative predictive value of MRI compared with mammography, an MRI can confirm whether BCS is feasible and better define extent of disease to increase the likelihood of clear margins. 9 In addition to mastectomy rates increasing from between 10% and 20%, 1, 10, 11 women are increasingly opting for bilateral surgeries including women without risk factors that indicate a clear survival benefit to contralateral prophylactic mastectomy (CPM). 12, 13 A number of patient and cancer characteristics have been associated with selection of CPM, including younger age, 4, 5, 10, [14] [15] [16] Caucasian race, 4, 10, 15 family history of breast cancer, 4, 10, 14, 16, 17 private health insurance, 15 DCIS histology, 4 and lobular tumor histology. 10, 16, 18 Recent studies have suggested CPM may coincide with the use of preoperative MRI 14, 19 with one study indicating that women who underwent MRI were twice as likely to have a CPM, 15 while other studies report CPM is associated with breast reconstruction at the time of mastectomy. 10, 16 There are very few studies that include breast reconstruction when examining the influence of preoperative breast MRI on surgical management including CPM.
Although many studies examining the outcomes and associations of preoperative MRI are published, 3, 5, 14, 20, 21 
| Statistical analysis
We computed frequency distributions for MRI use and patient and tumor CI 0.70-1.00) ( Table 3) . among women with DCIS. 16 At the same time, they found that rates of CPM rose from about 2% to 11%. 16 Within a National Comprehensive
Cancer Network (NCCN) study of 10 249 women, no differences were seen in mastectomy relative to BCS from 2000 to 2009, but there was a significant increase in bilateral mastectomy (from 13% to 30%) among women with mastectomy (23%). 24 A similar increase in CPM was reported in an analysis of SEER data between 2002 and 2012, with a tripling in use of CPM (3.9-12.7%) during that time. 13 A rise in reconstruction rates mirrors these trends, and is thought that greater reconstruction options and availability contributory to the increase in . 27 However a meta-analysis of nine studies, focused only on DCIS did not find a significant difference in mastectomy in relation to MRI, which may be due to measuring all mastectomies, rather than mastectomy as the index surgical treatment. 28 Our results in a national sample of over 13 000 women show a 32% increase in the adjusted odds of They found that a significantly higher proportion of women who had undergone mastectomy and preoperative MRI versus no MRI also underwent reconstruction (83.9% vs 63.6%). Our results add to this evidence given our national sample and large study size and our estimates adjusted for clinical and sociodemographic characteristics that could impact choice of reconstruction.
We were able to examine the association between preoperative MRI and surgical treatment by stage. Given that risk of second ipsilateral cancer events, subsequent contralateral breast cancer, and death are all related to stage, 11 in addition to other factors, the clinical rationale for the most aggressive surgical course is expected to vary by stage. DCIS poses a particular challenge, given the very low risk of breast cancer mortality (via subsequent invasive cancer), and the concomitant greater likelihood of harm from possible overtreatment. 31 We found the greatest relative increase in CPM frequency, comparing the MRI group to the no MRI group among those diagnosed with DCIS. A retrospective chart review of 214 patients with DCIS at an academic medical center found that preoperative MRI did not lead to change in the planned surgical management, but that it was associated with increased mastectomy and CPM. 32 Costs, complications, reoperation, and morbidity have also been noted as concerns with aggressive surgery for DCIS. 1, 19 In addition to the strength of our large, national sample comprised mostly of community-based settings, recent years of data, and BCSC data which includes women characteristics, this study also has limitations. We were unable to include MRI outcomes in this study, and thus could not determine whether MRI was causative in surgical management plans. We also did not have information on eligibility for BCS, margin status, or insurance information. Although we included many covariates, we could not identify women who were not clinical candidates for a particular surgical approach. We accounted for some established breast cancer risk factors, but did not have BRCA status.
Finally, and importantly-we could not account for women's or providers' preferences in use of MRI or in use of surgical treatments.
| CONCLUSION
Overall, our study reinforces previously reported trends of increasing mastectomy, CPM and reconstruction in relation to preoperative MRI, and provides new evidence related to the relationship of MRI and stage on surgical treatment and reconstruction for breast cancer. Given that more aggressive treatment of early stage breast cancer, is occurring, some component may be "overtreatment" relative to impact on medical outcomes including survival.
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